Literature DB >> 19016249

Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology.

Jérémie Haffner1, Eric Potiron, Sébastien Bouyé, Philippe Puech, Xavier Leroy, Laurent Lemaitre, Arnauld Villers.   

Abstract

BACKGROUND: To describe the precise location of peripheral zone (PZ) prostate cancers at various stages of development and to demonstrate their pattern of intraprostatic spread from their site of origin.
METHODS: PZ cancers defined as cancers located in peripheral zone (PZ) including the anterolateral part of PZ, were identified from radical prostatectomy specimens. PZ cancers morphometric histopathological study included largest surface area, volume and spatial distribution.
RESULTS: Out of 188 PZ cancers, 179 were <4 cm(3) and 168 <2 cm(3). PZ cancers were still confined to their zone of origin for volumes <2 cm(3). Between 2 and 4 cm(3), some cancers partially spread into the transition zone or anterior fibromuscular stroma. Sixty-four and 90% of PZ cancers <4 cm(3) were located in the lower and posterior half of the gland respectively. Ten percent were located in the anterior horn of PZ. Overall, non-index (second) cancers were located in the ipsi and contolateral side of the index cancer (largest) in 31% and 69% of cases, respectively. Cancers <2 cm(3) were confined to one lobe in 164 of 168 (98%) cases and not confined in 3 out of 11 (27%) cancers 2-4 cm(3). On vertical axis, only cancers >or=2 cm(3) involved both apex and base.
CONCLUSIONS: PZ cancers contours and locations are predictable and conform to histological zone boundaries if <2 cm(3) in volume. Knowledge of PZ cancers origin and pattern of spread in PZ are of importance for imaging diagnosis, guidance for biopsy and focal therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19016249     DOI: 10.1002/pros.20881

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

1.  Electronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties.

Authors:  S Gill; J Thomas; C Fox; T Kron; A Thompson; S Chander; S Williams; K H Tai; G Duchesne; F Foroudi
Journal:  Br J Radiol       Date:  2011-10-05       Impact factor: 3.039

2.  eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.

Authors:  Luc Furic; Liwei Rong; Ola Larsson; Ismaël Hervé Koumakpayi; Kaori Yoshida; Andrea Brueschke; Emmanuel Petroulakis; Nathaniel Robichaud; Michael Pollak; Louis A Gaboury; Pier Paolo Pandolfi; Fred Saad; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Gland and Zonal Segmentation of Prostate on T2W MR Images.

Authors:  O Chilali; P Puech; S Lakroum; M Diaf; S Mordon; N Betrouni
Journal:  J Digit Imaging       Date:  2016-12       Impact factor: 4.056

4.  Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer.

Authors:  Nadine Housri; Holly Ning; John Ondos; Peter Choyke; Kevin Camphausen; Deborah Citrin; Barbara Arora; Uma Shankavaram; Aradhana Kaushal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-06       Impact factor: 7.038

5.  Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI?

Authors:  Olivier Rouvière; Matthieu Papillard; Nicolas Girouin; Romain Boutier; Muriel Rabilloud; Benjamin Riche; Florence Mège-Lechevallier; Marc Colombel; Albert Gelet
Journal:  Eur Radiol       Date:  2012-01-07       Impact factor: 5.315

Review 6.  [Ultrasonography of the prostate gland : From B‑image through multiparametric ultrasound to targeted biopsy].

Authors:  F Steinkohl; A Luger; J Bektic; F Aigner
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

Review 7.  A biomedical engineering approach to mitigate the errors of prostate biopsy.

Authors:  Hashim Uddin Ahmed; Mark Emberton; Gordon Kepner; Jeremy Kepner
Journal:  Nat Rev Urol       Date:  2012-02-07       Impact factor: 14.432

Review 8.  Optimizing the diagnosis and management of ductal prostate cancer.

Authors:  Weranja Ranasinghe; Daniel D Shapiro; Miao Zhang; Tharakeswara Bathala; Nora Navone; Timothy C Thompson; Bradley Broom; Ana Aparicio; Shi-Ming Tu; Chad Tang; John W Davis; Louis Pisters; Brian F Chapin
Journal:  Nat Rev Urol       Date:  2021-04-06       Impact factor: 14.432

9.  Focal laser ablation of prostate cancer: definition, needs, and future.

Authors:  Pierre Colin; Serge Mordon; Pierre Nevoux; Mohammed Feras Marqa; Adil Ouzzane; Philippe Puech; Gregory Bozzini; Bertrand Leroux; Arnauld Villers; Nacim Betrouni
Journal:  Adv Urol       Date:  2012-05-16

Review 10.  Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer.

Authors:  Jesse D Le; Jiaoti Huang; Leonard S Marks
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.